Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • APM Steam Provides Expert Steam Trap Surveys to Document Operational Status and Provide Repair Recommendations for Biopharmaceutical and Pharmaceutical Facilities

    May 7, 2025, 08:24 AM by
    APM Steam is happy to announce its steam trap surveys for biopharmaceutical and pharmaceutical facilities. These surveys Increase energy efficiency, operational integrity, and safety in a facility’s steam distribution system.
    Full story
  • Empowering Precision: DoseMeRx Introduces Model-Switch Suggestion and Population Dosing for More Confident, Individualized Therapy

    May 7, 2025, 08:24 AM by
    DoseMe, a leading provider of Bayesian model-informed precision dosing (MIPD), today announced new features for its DoseMeRx platform: Model-Switch Suggestion and Population Dosing Matrix. These tools enhance clinical confidence and accelerate accurate therapy decisions, especially for drugs requiring narrow therapeutic window precision like vancomycin, busulfan, tacrolimus, and warfarin.
    Full story
  • Domainex Appoints Hayley French as Chief Executive Officer

    May 7, 2025, 08:24 AM by
    Domainex, a multi-award-winning, integrated drug discovery contract research organisation (CRO), has formally announced the appointment of Hayley French as its new Chief Executive Officer.
    Full story
  • Symbiosis Honoured with Prestigious King’s Award for Enterprise for International Trade

    May 7, 2025, 08:24 AM by
    Full story
  • First-of-its-Kind AI Tool Reveals the ‘Social Network’ of Cancer Cells

    May 7, 2025, 01:00 AM by User Not Found
    Bio-IT World | Researchers in Europe have developed a unique deep learning tool for analyzing spatial transcriptomics data to help decipher communication happening cell to cell as well as at the community level within tissues. It’s the first artificial intelligence (AI) method capable of measuring and interpreting a range of data from a cell's “social network."
    Full story
  • Symbiosis Completes Successful MHRA Audit of New Sterile Fill/Finish Facility, Expanding Global Manufacturing Capacity

    May 6, 2025, 08:38 AM by
    Full story
  • Illumina, Ovation Release GLP-1 Patient Dataset

    May 6, 2025, 01:00 AM by User Not Found
    Bio-IT World | PacBio this week announced it is licensing advanced DNA methylation detection methods developed by Professor Dennis Lo and colleagues at The Chinese University of Hong Kong (CUHK) and Centre for Novostics to improve the methylation detection capabilities in HiFi chemistry. The licensed technology is designed to enhance PacBio HiFi sequencing with improved detection of DNA base modifications—including 5-hydroxymethylcytosine (5hmC) and hemimethylated 5-methylcytosine (5mC)—in native DNA.
    Full story
  • Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

    May 1, 2025, 08:39 AM by
    Full story
  • Viz.ai Launches Viz 3D CTA™ to Deliver Enhanced Imaging and Accelerate Clinical Decision-Making

    May 1, 2025, 08:38 AM by
    New feature provides AI-enhanced 3D imaging to improve neurovascular visualization and streamline workflows.
    Full story
  • Illumina, Tempus AI Collaboration, CN Bio, Pharmaron Partnership, More

    May 1, 2025, 01:00 AM by User Not Found
    Bio-IT World | Illumina and Tempus AI collaborate to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation; CN Bio announced the establishment of a strategic partnership with Pharmaron to develop new applications to address unmet needs in drug discovery and development; and more.
    Full story
  • Gifthealth Appoints Chip Parkinson as Chief Executive Officer to Accelerate Growth and Innovation in Pharmacy Services

    Apr 30, 2025, 08:15 AM by
    Gifthealth, a technology-driven pharmacy care company dedicated to making prescription access easier and more affordable, is pleased to announce the appointment of Chip Parkinson as its new Chief Executive Officer.
    Full story
  • Sapio Sciences Introduces Biorepository Management Solution in Sapio Release 25.4

    Apr 30, 2025, 08:15 AM by
    Latest release of Sapio Platform streamlines sample workflows and delivers centralized, compliant biospecimen management
    Full story
  • PacBio Licenses New Methylation Tech for HiFi Sequencing, Will Deliver to Revio, Vega Systems

    Apr 30, 2025, 01:00 AM by User Not Found
    Bio-IT World | PacBio this week announced it is licensing advanced DNA methylation detection methods developed by Professor Dennis Lo and colleagues at The Chinese University of Hong Kong (CUHK) and Centre for Novostics to improve the methylation detection capabilities in HiFi chemistry. The licensed technology is designed to enhance PacBio HiFi sequencing with improved detection of DNA base modifications—including 5-hydroxymethylcytosine (5hmC) and hemimethylated 5-methylcytosine (5mC)—in native DNA.
    Full story
  • Ambience Healthcare Collaborates with Houston Methodist to Revolutionize Emergency and Inpatient Care

    Apr 29, 2025, 08:31 AM by
    Full story
  • Vector Laboratories and Spatomics Present Novel Method for Multiplexed Spatial Profiling of Glycans and Proteins at AACR

    Apr 29, 2025, 08:31 AM by
    Leader in manufacturing reagents and critical components for biomedical research partners with spatial biology solutions company to support simultaneous detection of 10+ markers in a single tissue sample using off-the-shelf antibodies and lectins
    Full story
  • Follow the Money: Cancer Platform Expansion, Wearable Device for Metabolic Health, More

    Apr 29, 2025, 01:00 AM by User Not Found
    Bio-IT World | Caris will expand their platforms, MI Cancer Seek and Caris Assure; Biolinq will bring the first autonomous intradermal glucose sensor to market; and more.
    Full story
  • Verista Highlights COUNTQ® Tray Inspection Systems

    Apr 28, 2025, 08:33 AM by
    The release highlights the COUNTQ® Tray Inspection System, an advanced AI-enabled inspection and reconciliation system designed to revolutionize the counting and verification of vials, syringes, ampoules, and other tray-loaded parts in pharmaceutical manufacturing.
    Full story
  • Stellaromics Announces First Deployment of Pyxa Platform in Europe

    Apr 25, 2025, 08:16 AM by
    Stellaromics, a pioneer in 3D spatial biology, announced its first European deployment of the Pyxa Platform through an early access partnership with Dr. Nigel Jamieson at the University of Glasgow. Dr. Jamieson’s team will use Pyxa’s 3D spatial multi-omics workflow to investigate tumor architecture and the surrounding microenvironment, work that could inform new biomarker discoveries and advance future cancer diagnostics and therapies.
    Full story
  • EpiCypher Launches Novel, Affordable DNA Methylation Sequencing Assays to Accelerate Drug Discovery

    Apr 25, 2025, 08:16 AM by
    EpiCypher® has announced the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery.
    Full story
  • Advancing Precision Medicine with Ethical AI and Standardized Data

    Apr 25, 2025, 01:00 AM by User Not Found
    Bio-IT World | The integration of artificial intelligence (AI) into precision medicine is transforming healthcare by enabling more personalized treatment strategies. However, along with these advancements come significant ethical considerations. AI must be implemented such that it enhances, rather than replaces, the physician-patient relationship while maintaining patient autonomy, transparency, and explainability in clinical decision-making.
    Full story
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9 (current)
  • 10
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy